Amplification of complete gag gene sequences from geographically distinct equine infectious anemia virus isolates.

The research focuses on studying and testing primers for amplifying the full-length gag genes from the Equine Infectious Anemia Virus (EIAV) from different countries. The study also shows the possibility of significant sequence variation in the gag genes of different EIAV strains.

Methodology

• The specific methodology designed for this research involves using a set of primers, both originally described and modified, to amplify full-length gag genes from various EIAV strains.
• The strains were collected from several countries including the USA, Germany, and Japan to provide geographical diversity in the sample set.
• The strains were inoculated into a primary horse leukocyte culture, which provided the essential environment for viral replication and gene amplification.
• Amplification was done by reverse transcription polymerase chain reaction (PCR), a common laboratory technique used to amplify the quantity of a specific region of DNA, in this case, the gag gene of EIAV.
• Each amplified gag gene was then cloned into a plasmid vector for sequencing. Plasmid vectors are used for cloning purposes, and sequencing allows for the reading of the genetic information in the gag gene.
• The detectable copy numbers of the target DNA were also determined during this process.

Results

• The research demonstrated that using a mixture of two forward primers and one reverse primer in the polymerase chain reaction could successfully amplify all the EIAV strains used in the study.
• However, the authors caution that further study is needed to determine if these primers can truly be considered universal and be effective for all EIAV strains.
• Contrary to the general acceptance that the nucleotide sequence of the gag gene is highly conserved (due to the use of gag-encoded capsid proteins as a common antigen for EIAV detection), the research unveiled significant sequence variation in the gag genes of different EIAV strains.

Conclusion

• The revealing of significant sequence variation in the gag genes from various strains implies there may be larger genetic diversity among EIAV strains that was previously believed. This has important implications for the detection and treatment of the virus.
• The research indicates that there may be a need to re-evaluate the effectiveness of the current serological tests for EIAV, which rely on a common antigen from the gag gene.